Autoantibodies against the basal cell layer: An association with chronic hepatitis B

Lenkei, Rodiça; Biberfeld, Gunnel; Buligescu, L; Țovaru, Șerban; Biberfeld, Peter; Hilborn, Lisa; Magnius, Lars O.

doi:10.1016/0090-1229(83)90129-0

Cited by 6 publications

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Close Association Between Basal Cell Layer Antibodies and Hepatitis B Virus-Associated Chronic Delta Infection

et al. 1984

View full text Add to dashboard Cite

Antibodies reacting in immunofluorescence with the basal cell layer of rat forestomach (BCLA) have been detected in 36 of 121 (30%) hepatitis B virus (HBV)-mediated chronic liver disease (CLD), in 1 of 30 (3%) HBV-negative CLD, in 3 of 36 (8%) alcoholic liver disease (with no correlation with serum HBV markers), in 1 of 25 (4%) primary biliary cirrhosis, in none of 19 HBV-related HBsAg-negative CLD and 60 healthy blood donors. Of 352 hospitalized patients with miscellaneous diseases (including immunological conditions), the antibodies were found in four (1%). In the 36 BCLA positive cases from HBV-mediated CLD, evidence of chronic delta infection was found in 34. The overall prevalence of BCLA in 68 delta cases was 50% (58% in chronic active hepatitis, 46% in cirrhosis), and in 28 delta negative cases was 4% (p less than 0.00002). BCLA of delta cases were mainly of the IgG class (38 of 41 sera), and high titers (up to 40,960) were found in the majority (66% greater than or equal to 1:640). The high titer BCLA has to be considered a marker of chronic delta infection in HBV cases.

show abstract